EMA Recommends Granting a Marketing Authorisation for Accordpharma Enzalutamide By Ogkologos - December 5, 2025 51 0 Facebook Twitter Google+ Pinterest WhatsApp It is a generic and hybrid of Xtandi, which has been authorised in the EU since 2013 Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR How we are working with industry to translate research into real... April 26, 2022 How to Prepare for Lung Cancer Treatment to Help With Recovery December 15, 2022 Snack Ideas and Tips for Better Sleep November 20, 2020 Researchers Have Discovered How Fat Cells Fuel The Spread Of Breast... December 19, 2019 Load more HOT NEWS Olivia Newton-John Shares Positive News On Breast Cancer: “I’m Winning Over... Turning the Life Sciences Vision into reality FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for HER2-Mutated NSCLC Check Out An All New GreaterGood.Com And Our Renewed Commitment To...
